BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 12411587)

  • 21. Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
    Hashimoto Y; Nakamura N; Kuze T; Abe M; Wakasa H
    Fukushima J Med Sci; 1997 Dec; 43(2):87-98. PubMed ID: 9640844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
    Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
    Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.
    Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK
    Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
    Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
    Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of cyclin D1 transcript levels, transcript type and protein expression with proliferation and histology among mantle cell lymphoma.
    Shakir R; Ngo N; Naresh KN
    J Clin Pathol; 2008 Aug; 61(8):920-7. PubMed ID: 18552173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.
    Carrère N; Belaud-Rotureau MA; Dubus P; Parrens M; de Mascarel A; Merlio JP
    Haematologica; 2005 Jun; 90(6):854-6. PubMed ID: 15951302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
    Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
    Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Aguilera NS; Bijwaard KE; Duncan B; Krafft AE; Chu WS; Abbondanzo SL; Lichy JH; Taubenberger JK
    Am J Pathol; 1998 Dec; 153(6):1969-76. PubMed ID: 9846986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of cyclin d1 expression by quantitative real-time, reverse-transcriptase polymerase chain reaction.
    Bijwaard KE; Lichy JH
    Methods Mol Med; 2004; 97():277-95. PubMed ID: 15064500
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
    Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
    Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
    Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
    Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
    Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis.
    Thieblemont C; Chettab K; Felman P; Callet-Bauchu E; Traverse-Glehen A; Berger F; Dumontet C; Cerutti C; Baseggio L; Salles G; Paultre C; Coiffier B; McGregor JL
    Leukemia; 2002 Nov; 16(11):2326-9. PubMed ID: 12399979
    [No Abstract]   [Full Text] [Related]  

  • 37. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
    Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
    Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma.
    Schmechel SC; LeVasseur RJ; Yang KH; Koehler KM; Kussick SJ; Sabath DE
    Leukemia; 2004 Apr; 18(4):841-55. PubMed ID: 14961037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
    Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
    Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative monitoring of cyclin D1 expression: a molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma.
    Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
    Int J Cancer; 2008 Dec; 123(12):2865-70. PubMed ID: 18798551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.